Anagrelide
434 interactions 313 cited referencesAnagrelide is used to decrease the number of platelets (a type of blood cell that is needed to control bleeding) in the blood of patients who have a bone marrow disorder, in which the body makes too many of one or more types of blood cells, such as essential thrombocythemia (condition in which the body makes too many p… Read the full Anagrelide drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Anagrelide Piroxicam Feldene An increased risk of bleeding Details Anagrelide Pitolisant Wakix Increased risk of QT interval prolongation Details Anagrelide Pixantrone Increased anagrelide exposure Details Anagrelide Ponesimod Ponvory An increased risk of QT interval prolongation Details Anagrelide Posaconazole Noxafil Increased risk of QT interval prolongation Details Anagrelide Prasugrel Effient Increased bleeding risk Details Anagrelide Primidone Mysoline An increased risk of QT interval prolongation Details Anagrelide Probucol Increased risk of QT interval prolongation Details Anagrelide Procainamide Procan® Increased risk of QT interval prolongation Details Anagrelide Prochlorperazine Increased risk of QT interval prolongation Details Anagrelide Proglumetacin An increased risk of bleeding Details Anagrelide Promethazine Phenadoz Increased risk of QT interval prolongation Details Anagrelide Propafenone Rythmol Increased risk of QT interval prolongation Details Anagrelide Propyphenazone An increased risk of bleeding Details Anagrelide Proquazone An increased risk of bleeding Details Anagrelide Protein C Ceprotin Increased risk of bleeding Details Anagrelide Protriptyline Increased risk of QT interval prolongation Details Anagrelide Prulifloxacin Increased anagrelide exposure Details Anagrelide Quetiapine Seroquel An increased risk of QT interval prolongation Details Anagrelide Quinidine Cardioquin® Increased risk of QT interval prolongation Details Anagrelide Quinine Increased risk of QT interval prolongation Details Anagrelide Quizartinib Vanflyta An increased risk of QT interval prolongation Details Anagrelide Ranolazine Aspruzyo Increased risk of QT interval prolongation Details Anagrelide Remibrutinib Rhapsido An increased risk of bleeding Details Anagrelide Reviparin Increased risk of bleeding Details Anagrelide Revumenib Revuforj An increased risk of QT interval prolongation Details Anagrelide Ribociclib Kisqali An increased risk of QT interval prolongation Details Anagrelide Rilpivirine Edurant Increased risk of QT interval prolongation Details Anagrelide Risperidone Perseris Increased risk of QT interval prolongation Details Anagrelide Ritonavir Norvir Increased risk of QT interval prolongation Details Anagrelide Rivaroxaban Xarelto Increased risk of bleeding Details Anagrelide Rofecoxib An increased risk of bleeding Details Anagrelide Rufloxacin Increased anagrelide exposure Details Anagrelide Salicylic Acid An increased risk of bleeding Details Anagrelide Salsalate Disalcid An increased risk of bleeding Details Anagrelide Selpercatinib Retevmo Increased risk of QT interval prolongation Details Anagrelide Selumetinib Koselugo Increased risk of bleeding Details Anagrelide Sertindole Increased risk of QT interval prolongation Details Anagrelide Sevoflurane Petrem Increased risk of QT interval prolongation Details Anagrelide Siponimod Mayzent An increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist